Effects of Oral L-Glutamine in Head and Neck Cancer Patients During Radiotherapy
Launched by KAOHSIUNG MEDICAL UNIVERSITY CHUNG-HO MEMORIAL HOSPITAL · Jan 5, 2017
Trial Information
Current as of June 15, 2025
Completed
Keywords
ClinConnect Summary
1. Written informed consent must be obtained before any study specific procedures are undertaken.
2. The process of the experiment A. head and neck cancer patients with surgery and radiotherapy are identified in clinic at the Department of Dentistry and the Department of Radiotherapy in Kaohsiung Medical University Chung-Ho Memorial Hospital.
B. Inform these patients about the value of this clinical trial in detail, and make sure that they understand all the meanings of each procedure in this clinical trial. Subsequently, the patients who are willing to participate in this study are enroll...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Histopathological diagnosis of malignant head and neck tumor.
- • able to open his or her mouth wider than the width of one finger during the assessment of oral mucositis.
- • Eastern Cooperative Oncology Group(ECOG)0-2
- • complete radiotherapy (six to seven weeks with targets involving oral cavity or oropharynx)
- Exclusion Criteria:
- • History of previous radiotherapy.
- • diabetes or nephritic or hepatic problems.
- • serious infection or sepsis.
- • distant metastases
About Kaohsiung Medical University Chung Ho Memorial Hospital
Kaohsiung Medical University Chung-Ho Memorial Hospital is a leading healthcare institution in Taiwan, dedicated to advancing medical research and improving patient care through innovative clinical trials. As a prominent sponsor, the hospital leverages its extensive expertise in various medical disciplines, state-of-the-art facilities, and a multidisciplinary team of professionals to conduct rigorous clinical studies. Committed to ethical standards and patient safety, the hospital collaborates with academic institutions and industry partners to facilitate groundbreaking research that contributes to the global medical community and enhances treatment options for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kaohsiung, , Taiwan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials